1.
Donica H, Korpysz M, Starosławska E, Malecha-Jędraszek A, Burska A, Kuć K, et al. The importance of the chromogranin concentration in evaluation of monitoring of treatment effectiveness with the somatostatin analogues in patients with neuroendocrine tumors. Curr. Issues Pharm. Med. Sci. [Internet]. 2012 Oct. 24 [cited 2025 May 23];24(4):159-65. Available from: https://czasopisma.umlub.pl/curipms/article/view/3066